Study Details

Back
Study ID 178-CL-046
Study Title A Randomized, Double-Blind, Parallel Group, Placebo and Active Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects with Symptoms of Overactive Bladder
Clinicaltrials.gov Identifier NCT00689104
Compound Name YM178 / mirabegron
Medical Indication or Disease Overactive bladder
Study Sponsor Astellas Pharma Global Development, Inc.
Collaborator Not Applicable
Study Start Date 28-Apr-2008
Study Completion Date 24-Mar-2009
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS